Eagle Pharmaceuticals,

Pharmaceutical Manufacturing, Outpatient Care Centers, Health Care and Social Assistance · 51 Employees
Phone Number: egrx@openboard.info
Email Address: egrx@openboard.info
  • Overview
  • Job Postings
  • Employees
Access 120 Verified Employees Profiles for Eagle Pharmaceuticals,Unlock Free Contacts Now
About
Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients’ lives. Eagle’s commercialized products include PEMFEXY®, RYANODEX®, BENDEKA®, BELRAPZO®, TREAKISYM® (Japan), and Byfavo® and Barhemsys® through its wholly owned subsidiary Acacia Pharma Inc. Eagle’s oncology and CNS/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. Additional information is available on Eagle’s website at www.eagleus.com.
Year Founded
2007
Social Media
LinkedinFacebookTwitter
Industry
Pharmaceutical Manufacturing, Outpatient Care Centers, Health Care and Social Assistance
HQ Location
--
Keywords
investigation and counselingbenefits verificationproduct credit replacement
Location
  • 50 Tice Blvd Suite #300 Woodcliff Lake, New Jersey 07677, US

Email Formats

Sign up for free credits and discover verified email addresses of Eagle Pharmaceuticals,
FormatExamples
first + last
andywarhol@eagleus.com
first_initial + last
awarhol@eagleus.com
first + last_initial
andyw@eagleus.com
first
andy@eagleus.com
last
warhol@eagleus.com
Get Verified Emails for 120 Eagle Pharmaceuticals, Employees

Frequently Asked Questions

Learn More about Eagle Pharmaceuticals,

Similar Companies

Pharmaceutical Manufacturing, Outpatient Care Centers, Health Care and Social Assistance

Get key business info for Eagle Pharmaceuticals, and other 100M companies. Start your seach.

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.